Fluxus Inc is a leading optofluidics company based in Santa Clara, CA, specializing in the development of ultrasensitive detection technologies and assay solutions for the advancement of disease detection, diagnosis, monitoring, and treatment. With a strong focus on photonics, engineering, chip fabrication, and reagent manufacturing, Fluxus aims to bridge the gap in clinical research and diagnostics through strategic partnerships and a portfolio of innovative products.
Founded in 2016 and acquired by Fujirebio Holdings, Inc. in 2022, Fluxus combines the ingenuity of a Silicon Valley startup with the stability and global reach of an established multinational corporation. As a wholly-owned subsidiary, Fluxus leverages its experienced and multidisciplinary team to continuously innovate and strive towards becoming the gold standard in single-molecule counting and ultrasensitive biomolecular testing.
Generated from the website